解剖学报 ›› 2018, Vol. 49 ›› Issue (6): 765-769.doi: 10.16098/j.issn.0529-1356.2018.06.012

• 组织学胚胎学发育生物学 • 上一篇    下一篇

氟比洛芬酯对股骨头置换高龄患者认知功能和炎症因子的影响

周志军 李映云*   

  1. 南通市第二人民医院麻醉科,江苏 南通 226000
  • 收稿日期:2018-06-06 修回日期:2018-06-28 出版日期:2018-12-06 发布日期:2019-02-28
  • 通讯作者: 李映云 E-mail:18012255668@163.com
  • 基金资助:
    氟比洛芬酯对高龄股骨骨折手术患者炎症反应及认知功能的影响

Effects of flurbiprofen axetil on cognitive function and inflammatory factors in elderly patients with femoral head replacement

ZHOU Zhi-jun LI Ying-yun*   

  1. Department of Anesthesiology in Nantong Second People’s Hospital,Jiangsu Nantong 226000, China
  • Received:2018-06-06 Revised:2018-06-28 Online:2018-12-06 Published:2019-02-28
  • Contact: LI Ying-yun E-mail:18012255668@163.com

摘要:

目的 观察氟比洛芬酯对股骨头置换高龄患者认知功能和炎症因子的影响。 方法 随机选取择期于腰硬联合阻滞麻醉(CSEA)下行股骨头置换手术的高龄患者75例,随机数字表将患者分为3组,每组25例,分别为:C组(对照组,使用生理盐水)、S组(溶剂组,使用临床凯纷制剂的溶剂脂微球)、K组(凯纷组,使用临床所用凯纷注射液)。3组分别记录术前24 h(T0)、手术结束时(T1)、术后3 h(T2)、术后12 h(T3)、术后24 h(T4) 时间点的血流动力学指标:心率(HR)、平均动脉压(MAP),并抽取外周静脉血3 ml,留存并以ELISA法测定血浆肿瘤坏死因子(TNF)-α、白细胞介素(IL)-6、IL-1β水平。并于T0、T2、T3、T4时间点通过简易智能状态检查法(MMSE)测试,以评价患者术后认知功能障碍(POCD)发生的情况。 结果 T0~T1时间点与C组及S组相比K组患者TNF-α、IL-6、IL-1β差异无显著性,T0~T2时间点与C组及S组相比K组患者MMSE差异无显著性;T2~T4时间点与C组及S组相比K组,K组患者TNF-α、IL-6、IL-1β血浆水平显著下降;T3~T4时间点与C组及S组相比K组,K组患者MMSE值显著增高;T2~T4 时间点,与C组及S组相比,K组患者恶心呕吐、呼吸抑制差异无显著性,疼痛评分显著低于C组及S组(P<0.05),术后POCD发生率,K组明显低于C组及S组。 结论 超前使用氟比洛芬酯可以降低围手术期炎症反应,减轻POCD的发生率及发生程度,且并不增加患者手术后恶心呕吐,呼吸抑制等并发症的发生。

关键词: 氟比洛芬酯, 术后认知功能障碍, 炎症因子, 股骨头置换术, 高龄患者

Abstract:

Objective To observe the effect of flurbiprofen axetil on cognitive function and inflammatory factors in elderly patients with femoral head replacement. Methods Seventy-five aged patients selectively undergoing femoral head replacement under combined spinal-epidural anesthesia(CSEA) were randomly selected and divided into three groups according to random number table, and each group had 25 patients: group C (control group, normal saline was administrated in clinical patients), group S (solvent group, the lipo microspheres for Kaifen preparations were administrated in clinical patients), group K (Kaifen group, Kaifen Flurbiprofen axetil injection was administrated in clinical patients). The hemodynamic indexes: heart rate (HR), mean arterial pressure(MAP) in three groups were recorded respectively at time points of the 24th hour before surgery (T0), the end of surgery (T1) and 3 hours (T2), 12 hours (T3) and 24 hours (T4) after surgery, and 3 ml peripheral blood was extracted and retained to detect the plasma levels of tumor necrosis factor(TNF)-α, interleukin(IL)-6 and IL-1β using the ELISA assay. Furthermore, the mini-mental status examination (MMSE) was performed at time points of T0, T2, T3 and T4 to evaluate the occurrence of postoperative cognitive dysfunction (POCD) in all patients. Results Compared to group C and S, there were no significant differences in TNF-α, IL-6 and IL-1β levels in patients of group K between time points of T0 and T1; Compared to group C and S, there were no significant differences in MMSE in patients of group K between time points of T0 and T2; Compared to group C and S, the plasma levels of TNF-α, IL-6 and IL-1β in patients of group K were significantly decreased between time points of T2 and T4; Compared to group C and S, the MMSE score in patients of group K was significantly increased between time points of T3 and T4; Compared to group C and S, there were no significant differences in occurrences of nausea and vomiting and respiratory depression in patients of group K between time points of T2 and T4, and the pain score in group K were significantly lower than those in group C and S (P<0.05). In addition, the postoperative incidence rate of POCD in group K was significantly lower than those in group C and S. Conclusion The advanced use of flurbiprofen can reduce the perioperative inflammatory response and decrease the incidence rate and extent of POCD, but can not increase the incidence rate of complications such as postoperative nausea, vomiting and respiratory depression.

Key words: Flurbiprofen, Postoperative cognitive dysfunction, Inflammatory factor, Femoral head replacement, Aged patient